Clinical Trial Update: Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

View source ↗

Summary

An observational trial sponsored by Novo Nordisk evaluates the effects of NovoMix 30, Levemir, and NovoRapid, used alone or in combination, in patients with Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoMix 30 (insulin aspart protamine fixed-dose combination)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED